Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Simms

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Urological Research|April 20, 2001
Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancerM S Simms, A Murray, G Denton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancerA Murray, M S Simms, D P Scholfield, et al.
Oncogenesis|April 17, 2013
Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXNE E Oldridge, H F Walker, M J Stower, et al.
British Journal of Cancer|November 14, 2013
HDAC inhibitor confers radiosensitivity to prostate stem-like cellsF M Frame, D Pellacani, A T Collins, et al.
Cell Death and Differentiation|January 28, 2014
DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferationD Pellacani, D Kestoras, A P Droop, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Urological Research|April 20, 2001
Production and characterisation of a C595 antibody-99mTc conjugate for immunoscintigraphy of bladder cancerM S Simms, A Murray, G Denton, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 5, 2001
Production and characterization of 188Re-C595 antibody for radioimmunotherapy of transitional cell bladder cancerA Murray, M S Simms, D P Scholfield, et al.
Oncogenesis|April 17, 2013
Retinoic acid represses invasion and stem cell phenotype by induction of the metastasis suppressors RARRES1 and LXNE E Oldridge, H F Walker, M J Stower, et al.
British Journal of Cancer|November 14, 2013
HDAC inhibitor confers radiosensitivity to prostate stem-like cellsF M Frame, D Pellacani, A T Collins, et al.
Cell Death and Differentiation|January 28, 2014
DNA hypermethylation in prostate cancer is a consequence of aberrant epithelial differentiation and hyperproliferationD Pellacani, D Kestoras, A P Droop, et al.
Pageof 2